These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. The facilitation of dopaminergic activity in the aged brain by (-)deprenyl. A proposal for a strategy to improve the quality of life in senescence. Knoll J. Mech Ageing Dev; 1985 May 13; 30(2):109-22. PubMed ID: 3927074 [Abstract] [Full Text] [Related]
12. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl. Karoum F. Br J Pharmacol; 1987 Feb 13; 90(2):335-45. PubMed ID: 3103805 [Abstract] [Full Text] [Related]
17. Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenyl. Riederer P, Konradi C, Schay V, Kienzl E, Birkmayer G, Danielczyk W, Sofic E, Youdim MB. Adv Neurol; 1987 Feb 13; 45():111-8. PubMed ID: 3030067 [Abstract] [Full Text] [Related]